arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

CLOVER HEALTH INVESTMENTS, CORP. /DE

CLOV
$4.46 ▼ -0.21 (-4.60%) at close
Healthcare ·Hospital & Medical Service Plans ·USHospital & Medical Service Plans
27 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
30
Health
Poor
Bearish
auto_awesome

Analytical Summary

CLOVER HEALTH INVESTMENTS, CORP. /DE faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $2.3B
Dividend Yield —
Revenue Growth 55.6% ↘
Op. Margin 3.8% ↗
ROIC 5.9% ↘
FCF / Share $0.05 ↘
Trailing P/E 89.2x
Price / Book 6.2x
FCF Yield 1.1%
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

27-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$743.17M
↑ +55.6% —
Net Income Profit after all expenses
$27.33M
— 0.0% —
Operating Margin Operating profit as % of sales
3.8%
↑ +3.3% 21th
FCF / Share Free cash flow per share
$0.05
↑ +391.8% —
Long-Term Debt Long-term obligations
$20.00M
— 0.0% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑
21
Cash Quality ↑
54

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 7 years · 27 quarters